(BG) Bunge Limited - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: CH1300646267
BG: Oilseeds, Grains, Vegetable Oils, Fats, Sugars, Biofuels
Bunge Limited, a stalwart in the agribusiness and food industry since 1818, stands as a testament to enduring reliability and adaptability. As a global leader, Bunge operates through four distinct segments, each playing a crucial role in the food supply chain.
The Agribusiness segment is the backbone of Bunges operations, specializing in the procurement, storage, and processing of key commodities such as soybeans, wheat, and corn. This segment not only connects farmers to manufacturers but also transforms oilseeds into essential products like vegetable oils and protein meals, catering to animal feed producers and biofuel companies.
Refined and Specialty Oils expand Bunges reach into consumer and industrial markets, offering a diverse range of products from cooking oils to renewable diesel feedstocks. Their expertise in refining palm, coconut, and olive oils, along with creating specialty ingredients like lecithin, underscores their commitment to innovation and meeting evolving market demands.
The Milling segment provides foundational ingredients for various food products, including wheat flours and corn milling products. Recognizing consumer trends, Bunge emphasizes whole grain and non-GMO options, aligning with the growing demand for healthier and more sustainable food choices.
The Sugar and Bioenergy segment showcases Bunges dedication to sustainability, producing ethanol and electricity from sugarcane byproducts. This approach not only supports renewable energy initiatives but also enhances their appeal to ESG-focused investors.
Financially, Bunge presents an attractive profile with a market cap of $9.744B and a forward P/E ratio of 9.23, indicating potential for future growth. As a dividend-paying stock with a history of resilience, Bunge offers stability and adaptability, making it a prime consideration for investors eyeing the agribusiness sector.
Additional Sources for BG Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BG Stock Overview
Market Cap in USD | 10,128m |
Sector | Consumer Defensive |
Industry | Farm Products |
GiC Sub-Industry | Agricultural Products & Services |
IPO / Inception | 2001-08-02 |
BG Stock Ratings
Growth 5y | 42.5% |
Fundamental | 4.17% |
Dividend | 72.2% |
Rel. Strength Industry | -25.2 |
Analysts | 4/5 |
Fair Price Momentum | 71.52 USD |
Fair Price DCF | 94.00 USD |
BG Dividends
Dividend Yield 12m | 3.23% |
Yield on Cost 5y | 9.34% |
Annual Growth 5y | 6.21% |
Payout Consistency | 99.8% |
BG Growth Ratios
Growth Correlation 3m | -75.8% |
Growth Correlation 12m | -85.6% |
Growth Correlation 5y | 67.2% |
CAGR 5y | 20.42% |
CAGR/Max DD 5y | 0.49 |
Sharpe Ratio 12m | 0.08 |
Alpha | -24.01 |
Beta | 0.11 |
Volatility | 28.26% |
Current Volume | 1099.9k |
Average Volume 20d | 1549.3k |
As of March 15, 2025, the stock is trading at USD 73.88 with a total of 1,099,887 shares traded.
Over the past week, the price has changed by -2.28%, over one month by +5.81%, over three months by -7.73% and over the past year by -19.12%.
Neither. Based on ValueRay Fundamental Analyses, Bunge Limited is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 4.17 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BG as of March 2025 is 71.52. This means that BG is currently overvalued and has a potential downside of -3.19%.
Bunge Limited has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy BG.
- Strong Buy: 4
- Buy: 2
- Hold: 4
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, BG Bunge Limited will be worth about 77.2 in March 2026. The stock is currently trading at 73.88. This means that the stock has a potential upside of +4.55%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 87.4 | 18.3% |
Analysts Target Price | 104.2 | 41.1% |
ValueRay Target Price | 77.2 | 4.5% |